<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Antimicrob Agents Chemother</journal-id><journal-id journal-id-type="pmc-domain-id">82</journal-id><journal-id journal-id-type="pmc-domain">aac</journal-id><journal-id journal-id-type="publisher-id">AAC</journal-id><journal-title-group><journal-title xml:lang="en">Antimicrobial Agents and Chemotherapy</journal-title></journal-title-group><issn pub-type="ppub">0066-4804</issn><issn pub-type="epub">1098-6596</issn><publisher><publisher-name>American Society for Microbiology (ASM)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC3195006</article-id><article-id pub-id-type="pmcid-ver">PMC3195006.1</article-id><article-id pub-id-type="pmcaid">3195006</article-id><article-id pub-id-type="pmcaiid">3195006</article-id><article-id pub-id-type="pmid">21859941</article-id><article-id pub-id-type="doi">10.1128/AAC.00617-11</article-id><article-id pub-id-type="publisher-id">0617-11</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Mechanisms of Action: Physiological Effects</subject></subj-group></article-categories><title-group><article-title>Dynamics of Mutator and Antibiotic-Resistant Populations in a Pharmacokinetic/Pharmacodynamic Model of <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> Biofilm Treatment <xref ref-type="fn" rid="FN1"><sup>&#9663;</sup></xref></article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Maci&#224;</surname><given-names initials="MD">Mar&#237;a D.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>P&#233;rez</surname><given-names initials="JL">Jos&#233; L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Molin</surname><given-names initials="S">Soeren</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Oliver</surname><given-names initials="A">Antonio</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1</label>Servicio de Microbiolog&#237;a and Unidad de Investigaci&#243;n, Hospital Universitario Son Espases, Palma de Mallorca, Spain</aff><aff id="aff2"><label>2</label>Center for Systems Microbiology, Department of Systems Biology, Building 301, Technical University of Denmark, Lyngby, Denmark</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Mailing address: 
<addr-line>Servicio de Microbiolog&#237;a and Unidad de Investigaci&#243;n, Hospital Universitario Son Espases, Ctra. Valldemossa, 79, 07010 Palma de Mallorca, Spain</addr-line>. Phone: 
<phone>34 871 206262</phone>. Fax: 
<fax>34 871 909708</fax>. E-mail: <email>mariad.macia@ssib.es</email>.</corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>2011</year></pub-date><volume>55</volume><issue>11</issue><issue-id pub-id-type="pmc-issue-id">201205</issue-id><fpage>5230</fpage><lpage>5237</lpage><history><date date-type="received"><day>3</day><month>5</month><year>2011</year></date><date date-type="rev-request"><day>23</day><month>7</month><year>2011</year></date><date date-type="accepted"><day>13</day><month>8</month><year>2011</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2012</year></date></event><event event-type="pmc-live"><date><day>01</day><month>05</month><year>2012</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-03-17 04:25:22.680"><day>17</day><month>03</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2011, American Society for Microbiology. All Rights Reserved.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder>American Society for Microbiology</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="zac5230.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="zac01111005230.pdf"/><abstract><p>Biofilm growth, antibiotic resistance, and mutator phenotypes are key components of chronic respiratory infections by <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> in cystic fibrosis patients. We examined the dynamics of mutator and antibiotic-resistant populations in <named-content content-type="genus-species">P. aeruginosa</named-content> flow-cell biofilms, using fluorescently tagged PAO1 and PAOMS (mutator [<italic>mutS</italic>] derivative) strains. Two-day-old biofilms were treated with ciprofloxacin (CIP) for 4 days (t4) at 2 &#956;g/ml, which correlated with the mutant prevention concentration (MPC) and provided an AUC/MIC ratio of 384 that should predict therapeutic success. Biofilms were monitored by confocal laser scanning microscopy (CLSM), and the numbers of viable cells and resistant mutants (4- and 16-fold MICs) were determined. Despite optimized pharmacokinetic/pharmacodynamic (PK/PD) parameters, CIP treatment did not suppress resistance development in <named-content content-type="genus-species">P. aeruginosa</named-content> biofilms. One-step resistant mutants (MexCD-OprJ or MexEF-OprN overexpression) were selected for both strains, while two-step resistant mutants (additional GyrA or GyrB mutation) were readily selected only from the mutator strain. CLSM analysis of competition experiments revealed that PAOMS, even when inoculated at a 0.01 proportion, took over the whole biofilm after only 2 days of CIP treatment outnumbering PAO1 by 3 log at t4. Our results show that mutational mechanisms play a major role in biofilm antibiotic resistance and that theoretically optimized PK/PD parameters fail to suppress resistance development, suggesting that the increased antibiotic tolerance driven by the special biofilm physiology and architecture may raise the effective MPC, favoring gradual mutational resistance development, especially in mutator strains. Moreover, the amplification of mutator populations under antibiotic treatment by coselection with resistance mutations is for the first time demonstrated <italic>in situ</italic> for <named-content content-type="genus-species">P. aeruginosa</named-content> biofilms.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>